Larson, Paul S.
Harvard University · University of Pittsburgh · University of California, San Francisco · Massachusetts General Hospital · Voyager Therapeutics (United States) · University of Pittsburgh Medical Center · The Ohio State University · Neurocrine Biosciences (United States)
6 papers on CoChatORCID 0000-0001-5211-4526
Most cited papers
- Verified
Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial
Marks, W. J., Ostrem, J. L., Verhagen, L., Starr, P. A., Larson, P. S., Bakay, R. A., Taylor, R., Cahn-Weiner, D. A., Stoessl, A. J., Olanow, C. W., et al. (2008) · The Lancet Neurology
Virus-based gene therapy researchParkinson's Disease Mechanisms and Treatments
Cited by 596
- Verified
Safety and tolerability of putaminal AADC gene therapy for Parkinson disease
Christine, C. W., Starr, P. A., Larson, P. S., Eberling, J. L., Jagust, W. J., Hawkins, R. A., VanBrocklin, H. F., Wright, J. F., Bankiewicz, K. S., & Aminoff, M. J. (2009) · Neurology
Parkinson's Disease Mechanisms and TreatmentsVirus-based gene therapy research
Cited by 445
- Verified
Results from a phase I safety trial of hAADC gene therapy for Parkinson disease
Eberling, J. L., Jagust, W. J., Christine, C. W., Starr, P., Larson, P., Bankiewicz, K. S., & Aminoff, M. J. (2008) · Neurology
Virus-based gene therapy researchParkinson's Disease Mechanisms and Treatments
Cited by 370
- Verified
Long-term wireless streaming of neural recordings for circuit discovery and adaptive stimulation in individuals with Parkinson’s disease
Gilron, R., Little, S., Perrone, R., Wilt, R., de Hemptinne, C., Yaroshinsky, M. S., Racine, C. A., Wang, S. S., Ostrem, J. L., Larson, P. S., et al. (2021) · Nature Biotechnology
Neuroscience and Neural EngineeringDeep Brain Stimulation and Movement Disorders
Cited by 343
- Verified
Magnetic resonance imaging–guided phase 1 trial of putaminal AADC gene therapy for Parkinson's disease
Christine, C. W., Bankiewicz, K. S., Van Laar, A. D., Richardson, R. M., Ravina, B., Kells, A. P., Boot, B., Martin, A. J., Nutt, J., Thompson, M. E., et al. (2019) · Annals of Neurology
Virus-based gene therapy researchParkinson's Disease Mechanisms and Treatments
Cited by 167
- Verified
Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial
Christine, C. W., Richardson, R. M., Van Laar, A. D., Thompson, M. E., Fine, E. M., Khwaja, O. S., Li, C., Liang, G. S., Meier, A., Roberts, E. W., et al. (2022) · Neurology
Parkinson's Disease Mechanisms and TreatmentsVirus-based gene therapy research
Cited by 89
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free